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ABSTRACT 
 Schizophrenia is a complex psychiatric disorder that likely emerges as a result of 
interacting genetic and environmental risk factors. A prominent hypothesis for the etiology of 
schizophrenia is that schizophrenia emerges as a result of pre- and/or perinatal viral infection-
induced inflammation in genetically predisposed individuals. This gene-environment interaction 
may be mediated by genetic regulators such as microRNA 137 (miR137), a regulatory RNA with 
a set of related SNPs that is highly associated with schizophrenia, and epigenetic phenomena 
such as RNA editing, which has been previously associated with schizophrenia and infection. 
Here I interrogate this gene-environment interaction by quantifying RNA editing of miR137, 
assessing the functional impact of this editing, and predicting its effects on schizophrenia risk in 
conjunction with a risk SNP. High-throughput RNA sequencing coupled to the PrimerID 
methodology revealed that miR137 is edited at a statistically significant level (p < 0.05) in both 
fetal human brain and adult mouse brain. Site-directed mutagenesis and luciferase assays 
demonstrated that A-to-I modification of certain pertinent bases in miR137 impart a large 
decrease in affinity to a target sequence. Finally, mathematical modeling and simulations based 
on empirical findings suggest that this RNA editing and a MIR137 schizophrenia-risk SNP 
significantly modulate inflammation-based schizophrenia risk burden (p < 2 x 10-16). These 
findings demonstrate that infection, the MIR137 gene, and RNA editing likely interact to 
promote schizophrenia risk, and thus this study serves to elucidate the cooperative influences of 
genetic and environmental risk factors on schizophrenia.  
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INTRODUCTION 
 The Psychiatric Genetics Consortium released a landmark paper in 2014, which identified 
numerous risk loci that are associated with schizophrenia[1]. One of the most highly associated 
haplotypes is positioned around the MIR137 locus, which codes for a microRNA that targets 
other schizophrenia-associated genes such as CACNA1C and TCF4[1-42]. This discovery has 
prompted considerable functional work to determine the effects of various key MIR137 single 
nucleotide polymorphisms (SNPs) on the expression of miR137 and downstream targets[2, 3, 5, 
43]. This work has led to the identification of gene-expression effects resulting from MIR137 
SNPs, such as the downregulation of miR137 and the upregulation of its schizophrenia-
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associated targets[2, 3, 5, 43]. This suggests that MIR137 plays a central role in the etiology of 
schizophrenia.  
It has been discovered in recent years that microRNAs are subject to A-to-I editing by the 
various forms of the adenosine deaminase acting on RNA (ADAR) enzyme[44-52]. This 
phenomenon, which causes specific adenosine bases in double stranded RNA to be converted to 
inosine, has been determined to have functional impacts on microRNA biogenesis and 
subsequent targeting, even leading to altered sets of target genes for a given microRNA[44-51]. 
In prior high-throughput RNA sequencing experiments, our group has identified possible non-
background levels of A-to-I editing in the miR137 sequence (data not shown). I hypothesize that 
such A-to-I editing of miR137 and/or the interaction between the ADAR enzymes and miR137 
may be involved in the etiology of schizophrenia. 
The phenomenon of RNA editing has actually been associated with schizophrenia in a 
number of ways[53-55]. For example, the age of onset of schizophrenia is associated with 
expression levels of the ADAR1-A isoform and expression levels of multiple ADAR isoforms 
are significantly altered in dorsolateral prefrontal cortex tissue samples from patients with 
schizophrenia[53]. Of note is the fact that ADAR1-A is the interferon-inducible isoform of 
ADAR1, which offers an interesting connection to the viral hypothesis of schizophrenia[56-65]. 
This hypothesis suggests that schizophrenia may develop in genetically predisposed individuals 
following an intense immune response from the mother, likely triggered by a viral infection, 
while the individual is still in the womb[56-65]. The altered expression of ADAR1-A in the brain 
of patients with schizophrenia, coupled to its interferon-inducible (and thus infection-inducible), 
lends support to the viral hypothesis of schizophrenia and simultaneously offers an etiological 
clue.  
RNA Editing of Human MIR137 Harish Pudukodu 
 Page 7 
Apart from ADAR1-A’s standard RNA editing role in the nucleus, it also acts as an 
inducing agent for Dicer, an important enzyme in the biogenesis pathway of miRNAs[66, 67]. 
More specifically, ADAR1-A is capable of increasing Dicer’s Vmax four-fold, and thus enables 
Dicer to produce mature miRNAs at a faster rate[66]. Interestingly, it seems that ADAR1-A 
preferentially performs the latter cytoplasmic function because of its tendency to localize to the 
cytoplasm in greater proportion compared to other ADAR forms[68].  
Given the facts that miR137 may experience A-to-I RNA editing, miR137 almost 
certainly interacts with ADAR1-A via Dicer, and ADAR1-A is induced by interferon (which is 
released during viral infection), I hypothesize that infection-mediated interferon release and 
schizophrenia-associated SNPs in MIR137 interact with ADAR1-A via A-to-I editing of miR137 
and Dicer-mediated biogenesis to influence schizophrenia risk. This hypothesis can be parsed 
into three specific aims: (1) to determine if miR137 is subjected to A-to-I RNA editing in fetal 
human and adult mouse brain, (2) to determine if such editing has any functional consequences 
in vitro, and (3) to determine if a schizophrenia-associated MIR137 SNP modulates marginal 
schizophrenia risk changes due to infection-mediated interferon release and subsequent ADAR1-
A induction. I tested the first specific aim using a high-throughput RNA sequencing 
methodology called PrimerID[69, 70], I tested the second specific aim using site-directed 
mutagenesis and luciferase assay data, and I tested the third specific aim using a predictive 
modeling approach implemented in MATLAB.   
 
MATERIALS AND METHODS 
Computational RNA Analyses 
Prediction of A-to-I editing likelihood by hADAR1 was performed using InosinePredict, 
which use previously described methods to predict RNA editing activity for dsRNA 
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molecules[71]. In short, the algorithm has been trained on hADAR1/dsRNA reaction data to 
assign editing likelihood scores at adenosine bases in a custom dsRNA sequence based on nearby 
ribonucleotide identities[71]. The sequence for the human precursor miR137 molecule was found 
using the UCSC Genome Browser[72] and this sequence was entered into the InosinePredict web 
application to produce A-to-I edit prediction data.  
Secondary structure prediction for pre-miR137 was performed using RNAstructure, which 
utilizes thermodynamic models and nearest neighbor parameters to predict RNA secondary 
structure[73]. Visual output from this software was analyzed systematically to identify plausible 
and implausible sites of A-to-I RNA editing. Implausible sites were deemed to be all unpaired 
bases in the miR137 secondary structure and plausible sites were deemed to be paired adenosine 
bases in the miR137 secondary structure.  
 
RNA Preparation and Sequencing 
We used a previously described protocol to construct Primer ID MiSeq sequencing 
libraries[70]. In brief, cDNA was made using primers containing a block of random nucleotides 
(Primer ID). The cDNA primer sequences were 5’- 
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNNNNNNNNTAGCTGCCGCTG
GTACTCTCCTCGA -3’ and 5’- 
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNNNNNNNNTACCTGCCGCTG
GTACTCTCCTCGA -3’ for human and mouse sample, respectively. After purification, cDNA 
was amplified using two rounds of PCR and MiSeq indexed primers were incorporated. The 
primer sequence of the first round PCR forward primer was 5’- 
GCCTCCCTCGCGCCATCAGAGATGTGTATAAGAGACAGNNNNCCTCTGACTCTCTTC
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GGTGA-3’ for both human and mouse samples. Purified and pooled libraries were sequenced 
using Illumina MiSeq 150 bp pair-end sequencing. We used the Illumina bcl2fastq pipeline 
(v.1.8.4) for the initial processing of sequencing data, followed by the previously described 
Primer ID consensus pipeline[70] to create template consensus sequences (available at 
https://github.com/SwanstromLab/PID). We analyzed mutations at each nucleotide positions of 
the template consensus sequences.  
 
Mutagenesis, Luciferase, and RT-PCR Experiments 
Plasmid constructs for each combination of edit were created using site-directed 
mutagenesis and standard cloning procedures. For the luciferase assays, Hek293 cells were split 
into a 96 well plate with 3*104 cells per well with 100 µL of media per well. Approximately 18 
hours after splitting, a mixture of pLuc137TRGTx4, Renilla, optiMEM, Lipofectamine 2000, and 
the desired mutagenic sequence (or the wild variation or the control pCMVPL) was made and 
incubated for 20-30 minutes. After incubation, these mixtures were added to each of the wells. 
This left triplicate wells for each transfected DNA sequence. After 2 days of growth, the media 
was dumped, the cells were was once, and then lysed passively for 15 minutes. Finally, a dual-
luciferase assay system was used to measure both Firefly and Renilla Luciferase levels.  
For the quantitative RT-PCR assays, Hek293 were split into 3 12 well plates with 2*105 
cells per well and 1 mL of media per well. 28 hours later, the mutagenic and control plasmids 
were mixed with lipofectamine 2000 and incubated for 20-30 minutes. These mixtures were 
randomly added to wells of each of the plates, leaving triplicate wells for each transfected DNA 
sequence again. After 3 days, Trizol Reagent was added to each of the wells and RNA was 
purified using the Thermofish Trizol Reagent protocol. cDNA was then created using the 
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purified RNA using a NCode™ VILO™ miRNA cDNA Synthesis Kit. Finally, some of these 
cDNA was used to run and RT-PCR using a SYBR Green Master Mix. 
 
Mathematical Modeling of MIR137 System Dynamics 
The temporal dynamics of interferon (IFN), ADAR1-A, miR137 (MIR), TCF4 mRNA 
(TM) and protein (TP), dendritic cells (DC), and inflammation burden (IB) in response to an 
infection were modeled using a system of coupled ordinary differential equations (ODEs) 
implemented in MATLAB. This modeling system encapsulated the interactions among these 
relevant physiological entities, as they relate to inflammation, through standard biochemical 
kinetics paradigms such as mass-action kinetics and Michaelis-Menten kinetics. Infection was 
modeled as entrance of pathogen, which incorporated a custom function to specify square-wave 
input. 
The ODEs used in this system are as follows: 
dPathogen
dt
= SquareWave(t, pathogen period, pathogen length, pathogen high, pathogen low) − (pathogen clearance rate) ∗ Pathogen 
dIFN
dt
= (IFN release parameter) ∗ Pathogen ∗ DC − (IFN degradation rate) ∗ IFN 
dADAR1A
dt
= (ADAR1 − A synthesis parameter) ∗ IFN − (ADAR1 − A degradation rate) ∗ ADAR1A 
dMIR
dt
= (basal miR137 transcription rate) ∗ (1 − 0.3 ∗ (binary SNP presence)) ∗ (1 + 2.98 ∗ (
ADAR1A
20
)) − (miR137 degradation rate) ∗ MIR 
E = Proportion of MIR that is edited = (basal editing rate) ∗ (1 +
0.6 ∗ ADAR1A
ADAR1B
) 
dTM
dt
= (basal TM transcription rate) − (TM degradation rate) ∗ TM −  
0.16 ∗ E ∗ MIR ∗ TM ∗ (Targeting Vmax)
(Targeting Km) + TM
−
(1 − E) ∗ MIR ∗ TM ∗ (Targeting Vmax)
(Targeting Km) + TM
 
dTP
dt
=
TM ∗ (Protein Vmax)
(Protein Km) + TM
−
TP ∗ (Degradation Vmax)
(Degradation Km) + TP
 
dDC
dt
= (basal DC production rate) + (TCF4 stimulation factor) ∗ TP − (DC degradation rate) ∗ DC 
dIB
dt
= (inflammation factor) ∗ IFN 
 Sensitivities to parameters were calculated via one-by-one variation of parameter values 
and subsequent comparisons of final IB.  
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Statistical Analyses 
Edit frequency significance testing was performed in Microsoft Excel, haplotype 
frequency analyses were performed in MATLAB, luciferase and RT-PCR data analyses were 
performed in JMP and R, and statistical analyses of the mathematical modeling results were 
performed in R. Edit and haplotype frequency analyses employed the Poisson distribution to 
model probabilities of individual edit events, while the remaining statistical analyses utilized 
standard Gaussian procedures.   
 
RESULTS 
Pre-miR137 is a predicted target of hADAR1 
Based on consensus sequence data derived from preliminary, exploratory high-throughput 
RNAseq experiments performed by our group, we hypothesized that the precursor miR137 
molecule would experience A-to-I RNA editing at three sites: Bases 29, 69, and 74 (Figure 1). 
To initially assess the biochemical and physical plausibility of this potential editing activity, we 
utilized a published hADAR1 activity prediction tool known as InosinePredict[71]. 
InosinePredict uses predictive algorithms developed from hADAR1/dsRNA reaction data to 
assign a score to each base of a queried dsRNA molecule, reflecting the likelihood of A-to-I 
editing by hADAR1[71]. We analyzed the likelihood of editing of MIR137 using the pre-miR137 
sequence fed into the InosinePredict tool.  
The InosinePredict algorithm predicted that many, but not all, of the adenosine bases in the 
precursor miR137 molecule would be edited at a significant level by hADAR1 (Figure 1a). Of 
note, the three initially hypothesized editing sites in pre-miR137 were among the high likelihood 
hADAR1 target sites in the sequence (Figure 1a).  
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Because the InosinePredict tool assumes a perfectly paired dsRNA molecule, the predicted 
A-to-I editing sites were assessed for structural feasibility of editing. To this end, we used a 
published web server-based software known as RNAstructure to predict the secondary structure 
of pre-miR137[73]. Secondary structure prediction via RNAstructure revealed that some of the 
predicted hADAR1 sites are not biologically plausible A-to-I editing sites because those bases 
are not paired in a double-stranded manner (Figure 1b). These implausible sites of predicted 
editing were ignored in downstream analyses.  
 
Adult mouse and fetal human brains exhibit statistically significant levels of A-to-I MIR137 
editing 
Following our computational interrogation of the plausibility and likelihood of A-to-I 
editing in pre-miR137, we sought to determine if the phenomenon is truly exhibited in brain 
tissue from adult mice and fetal humans. To accomplish this, we utilized a published method 
called PrimerID[70] in conjunction with high-throughput RNA sequencing. PrimerID enables 
one to parse out the contribution to nucleotide-level read variability from original biological 
variation (as opposed to errors introduced from library preparation and sequencing steps) using 
randomized transcript barcodes[70], and thus this system allowed us to determine the true 
frequency of A-to-I editing in our samples.  
Whole RNA samples from adult mouse brain and fetal human brain tissues were used for 
library preparation and subsequent sequencing. Read results from high-throughput RNAseq were 
aligned to mouse and human genomes (depending on the sample origin) and consensus reads 
were constructed. Base-level changes were statistically analyzed for significance using a Poisson 
distribution to determine sites in MIR137 that experienced significant A-to-I editing. A multitude 
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of sites, many of which corresponded directly with predicted locations, were identified as 
significant A-to-I editing sites in both adult mouse brain and fetal human brain (Supplementary 
Table 1). Among these sites, the highest rates of editing were determined to be at the 
hypothesized editing sites (positions 29, 69, and 74) in both mouse and human (Table 1a).  
To interrogate the potential interdependence of A-to-I editing at the high frequency sites in 
fetal human and adult mouse, haplotypes and associated frequencies were determined from the 
sequence read data. A MATLAB script was written to 1) predict the frequencies of edit 
combinations based on the assumption of independent editing at each site, 2) calculate the true 
frequencies of edit combinations from haplotype data, and 3) calculate fold differences between 
predicted and observed frequencies. This analysis revealed that RNA editing at each high 
frequency site was only loosely coupled in adult mouse brain and was uncoupled in fetal human 
brain (Table 1b).  
Of the significant A-to-I editing sites identified from the analysis of the RNAseq data, we 
were interested in identifying the sites that are conserved across mouse and human for enriched 
editing frequency. To this end, editing frequencies were normalized across the two test species 
and compared. Of the twelve total significant editing sites identified across both species, only 
editing at positions 69 and 74 (two of the initially hypothesized editing sites) were conserved and 
enriched in both fetal human brain and adult mouse brain (Figure 2). Both of these positions in 
the precursor miR137 molecule are present in the mature miRNA.  
 
A-to-I editing of MIR137 significantly changes target affinity 
To determine possible functional consequences of A-to-I editing of pre-miR137 on 
mature miR137’s targeting capacity, a series of mutagenesis experiments were performed. All 
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combinations of the three edits (WT, a29g, a69g, a74g, a29g+a69g, a29g+a74g, a69g+a74g, all 
three a-to-g) were made using site-directed mutagenesis in otherwise identical miR137 
expression constructs. Subsequently, a luciferase assay system was designed to determine 
binding activity by each of the miR137 forms. A reporter plasmid was constructed that included 
a luciferase expression cassette coupled to multiple repeats of the antisense sequence of mature 
miR137.  
Each of the miR137 constructs (along with a positive and negative control) was tested 
using this luciferase assay system, where miRNA binding to the antisense repeats would lead to 
reduced luciferase activity. All of the miR137 edited forms, except for the single a74g form, led 
to increased luciferase activity compared to the WT form of miR137 (Figure 3). This outcome 
could be caused either by correlated differences in expression of miR137 from each construct or 
by truly biological differences in targeting behavior caused by RNA editing.  
To test the possibility that the luciferase data could be explained by expression 
differences, each of the luciferase experiments were coupled to RT-PCR experiments to 
determine expression levels of each construct. Regression of the luciferase data by the RT-PCR 
data revealed that the luciferase data were not significantly associated with the RT-PCR 
expression data (Supplementary Figure 1). As such, the increased luciferase activities observed 
for the majority of the edited forms of miR137 are not due to differences in expression levels of 
each construct. This suggests that the modification of A-to-I in select positions of miR137 
imparts altered targeting activity to the mature microRNA.  
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MIR137 SNP rs1625579 modulates inflammatory burden in a manner significantly dependent 
on miR137 A-to-I editing 
 To investigate the role of miR137 A-to-I editing in the potential gene-environment 
interaction system posited by the viral hypothesis of schizophrenia, a mathematical modeling 
framework was constructed (Figure 4) and simulated using MATLAB. This modeling 
framework consisted of a set of coupled nonlinear ordinary differential equations (ODEs), which 
were solved using MATLAB’s ode45 ODE solver. The parameterization of the model allowed 
for the modification of production/elimination rates, binding affinities, the basal editing rate, and 
presence of a single well-studied MIR137 SNP: rs1625579, which has been shown to reduce 
miR137 expression[2, 43]. 
 Schizophrenia risk was modeled as inflammatory burden, which was calculated as the 
time-integral of interferon (IFN) level. This methodology is supported by numerous findings that 
indicate that inflammation and dysregulated general immune response are likely etiological 
factors for schizophrenia[56, 58, 61-65]. IFN release was modeled using brain dendritic cells, 
which are targets of TCF4-mediated induction[25]. These inclusions, along with the other model 
structures, resulted in biologically plausible dynamics for the various species of interest (e.g. 
miR137 and TCF4 protein levels) (Supplementary Figure 2).  
 To test the influence of the SNP on inflammatory burden (and thus schizophrenia risk), 
the model was simulated with and without the presence of the risk SNP under a periodic 
infection spike input (Figure 5). These simulations revealed that the presence of the SNP causes 
larger marginal changes in inflammatory burden in response to infection, which accumulate over 
time (Figure 5). To assess whether this influence of the risk SNP on inflammatory burden 
significantly depends on RNA editing, the model was simulated with and without the presence of 
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the risk SNP and with different basal RNA editing rates under a near-continuous infection input. 
For each RNA editing rate tested, an inflammatory burden fold change was calculated 
(inflammatory burden with the SNP over the inflammatory burden without the SNP). These fold 
changes were analyzed via linear regression against the various RNA editing rate values, and this 
analysis revealed that the basal RNA editing rate significantly affects the inflammatory burden 
fold change due to the SNP (p < 2 x 10-16) (Figure 6). This indicates that the phenomenon of 
miR137 A-to-I RNA editing plays a significant role in schizophrenia risk upon infection.  
 
DISCUSSION AND CONCLUSIONS 
MIR137 is subjected to A-to-I RNA editing 
 To test the hypothesis that miR137 is subjected to A-to-I RNA editing by an ADAR 
enzyme (likely ADAR1 due to its prevalence in the brain[44, 46, 47, 49, 66, 71, 74, 75]), the 
precursor to mature miR137 (pre-miR137) was analyzed using predictive bioinformatics and the 
editing rate was estimated using high throughput RNA-sequencing and PrimerID[69, 70]. The 
computational analyses suggested that certain bases of pre-miR137 were likely to be subjected to 
A-to-I RNA editing by ADAR1 at a significant rate (Figure 1) and the RNA-sequencing results 
recapitulated these predictions in both fetal human brain and adult mouse brain (Table 1). Upon 
further analysis of these RNA-sequencing data, it was revealed that the sites with the highest 
relative editing rates in adult mouse brain are conserved in fetal human brain and that these sites 
are present in the final mature miR137 (Figure 2), which suggests that these conserved edits 
have functional consequences. All of this evidence taken together leads to the conclusion that 
there is a high likelihood that miR137 is subjected to A-to-I editing in vivo.  
 It is important to note that the raw editing rates in the fetal human samples are far lower 
than those in the adult mouse samples (Table 1). This is likely because RNA editing rates 
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increase with neural development[76] and the fetal human brain tissue used in this study was 
inferior in quality to the adult mouse brain tissue used in this study. Given that primates typically 
exhibit higher RNA editing rates than nonprimates[77], one would expect that high quality adult 
human brain tissue would present with higher rates of miR137 A-to-I editing. Further molecular 
transcriptomic work must be done to test this prediction and determine the true rates of miR137 
A-to-I editing in adult human brains. 
 
A-to-I RNA editing of MIR137 changes target affinity 
 Given the likelihood of in vivo A-to-I editing of miR137, we were interested in 
determining whether such editing would have functional consequences with respect to miR137 
targeting affinity. To address this question, miR137 constructs with point mutations (induced by 
site directed mutagenesis) corresponding to edit combinations were assayed for antisense target 
binding activity in a custom luciferase reporter-based system. This set of experiments revealed 
that many of the A-to-I (A-to-G) edit combinations led to lower binding affinity between 
miR137 and the antisense target (Figure 3). 
 The results of the above assay suggest that miR137 A-to-I editing has meaningful 
functional consequences in vivo in the form of altered target affinity and subsequent changes in 
gene expression networks, but further research must be done to confirm this finding and 
elucidate its mechanistic nature. Given that this assay employed antisense repeats as pseudo-
targets, it may still be plausible that miR137 targeting capacity may be unchanged in vivo with 
respect to real target sequences. To address this concern, future work must employ real target 
sequences (derived from real target mRNAs) to better assess binding affinity changes. 
Additionally, future in situ investigations may be useful to determine the precise mechanistic 
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consequences of miR137 RNA editing (at the biochemical and cellular levels). That being said, 
the presence of this luciferase reporter assay-based in vitro data coupled to the previously 
discussed evidence for editing conservation suggests that there is a true in vivo consequence to 
the miR137 A-to-I editing identified in this study.  
 
Schizophrenia risk burden from infection is modulated by a SNP in MIR137 and miR137 
editing rate 
 Because of the IFN-inducible nature of ADAR1[44-50, 66, 71, 77], the association 
between RNA editing and ADAR levels with schizophrenia[53, 70], the strong association 
between MIR137 SNPs and schizophrenia, and the likely interaction between ADARs and 
miR137 discovered in this study, it is likely that miR137 (and its associated genetic variation) 
and RNA editing would play central roles in the development of schizophrenia risk from viral 
infection, as posited by the viral hypothesis of schizophrenia. Furthermore, the role of RNA 
editing in schizophrenia etiology is likely two-fold because of ADAR1’s ability to both edit 
double stranded RNA molecules and promote Dicer activity[66]. To test the prediction that 
miR137 A-to-I editing and MIR137 genetic variation (implemented here as the rs1625579 SNP) 
interact to influence schizophrenia risk upon viral infection, a mathematical modeling framework 
based on literature-derived biochemical kinetics and genetics data was constructed and 
simulated. These computational experiments confirmed the aforementioned prediction: presence 
of the rs1625579 SNP considerably modified inflammatory burden (Figure 5) and miR137 
editing significantly influenced this SNP effect (Figure 6).  
 These findings lend credence to the viral hypothesis of schizophrenia and offer a 
plausible partial mechanism for the etiology of schizophrenia, but additional empirical work 
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must be done to solidify the connections between viral infections, miR137 A-to-I editing, and 
schizophrenia. Schizophrenia is a highly complicated and polygenic disease that almost certainly 
arises from varied gene-environment interactions[1]. Given this inherent mass of complexity, it 
is unlikely that any one study will provide more than a fraction of the information necessary to 
understand schizophrenia. That being said, the findings in the present study related to the 
influence of gene-environment interactions on schizophrenia risk allow for the development of a 
basic schizophrenia risk framework, which would assist public health specialists and healthcare 
practitioners as they work to prevent and treat this debilitating disorder (Figure 7). The present 
study suggests that schizophrenia risk arises from genetic risk elements, environmental risk 
elements, and the interaction among those genetic and environmental factors (Figure 7). Further 
integrative and interdisciplinary work is crucial for the development of a quantitatively precise 
model of schizophrenia risk, but the conceptual model posited here would likely be a useful 
guiding framework for subsequent model development.  
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TABLES AND FIGURES 
Figure 1 
 
The precursor to mature miR137 is predicted to undergo A-to-I RNA editing by ADAR1 at 
significant levels. (A) This graph displays the output from InosinePredict, which represents 
relative ADAR1-based editing likelihoods at the various positions along pre-miR137. The bars 
colored in red represent sites that were previously hypothesized to be editing sites based on in-
house data and the purple base numbers represent implausible editing sites. (B) This figure 
corresponds to the secondary structure of pre-miR137, as predicted by RNAstructure.  
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Table 1 
Table 1a 
 
Table 1b 
 
MicroRNA 137 is subjected to A-to-I editing in vivo at multiple base positions. (A) This 
table displays total editing rates by species at the three hypothesized edit sites in miR137, as 
determined from high throughput RNA-sequencing data. (B) This table portrays the results of 
further analysis of the RNA-sequencing data to determine frequencies of distinct edit 
combinations. Strict combinations refer to edits solely at the enumerated sites (e.g. “1” 
corresponds to editing at only site 1).  
 
Index Table Raw Frequency Table
Index Position in pre-mir137 Base Edit Frequency in Adult Mouse Edit Frequency in Fetal Human
1 29 29 0.032675289 0.00046463
2 69 69 0.055820286 0.00092926
3 74 74 0.080326753 0.00139389
SPECIES
Strict Combination Table
Strict Indexed Edit Combination Actual Combination Frequency Predicted Combination Frequency Fold difference (Actual/Predicted)
1 0.024506467 0.028373157 0.863720137
2 0.039482641 0.049658991 0.795075381
3 0.061946903 0.073364702 0.844369306
12 0.002722941 0.001677432 1.623278902
13 0.004765146 0.002478188 1.922834589
23 0.012933969 0.004337351 2.981997362
123 0.000680735 0.000146511 4.646291942
SPECIES
Strict Combination Table
Strict Indexed Edit Combination Actual Combination Frequency Predicted Combination Frequency Fold difference (Actual/Predicted)
1 0.00046463 0.000463551 1.002327258
2 0.00092926 0.000927534 1.001861331
3 0.00139389 0.001391948 1.001395403
12 0 4.31E-07 0
13 0 6.47E-07 0
23 0 1.29E-06 0
123 0 6.02E-10 0
NOTE: Strict combination implies that non-specified indices are NOT edited
NOTE: Strict combination implies that non-specified indices are NOT edited
ADULT MOUSE
FETAL HUMAN
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Figure 2 
 
A-to-I RNA editing is conserved at relatively high levels at two distinct positions present in 
mature miR137. This graph illustrates the normalized editing rates (based on species-specific 
averages) at all of the observed edit sites for each species. Positions 69 and 74 exhibit relatively 
high normalized editing in fetal human brain and adult mouse brain.  
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Figure 3 
 
A-to-G modifications to miR137 impart changes in target affinity in vitro. This figure 
displays the results of luciferase assays performed to quantify miR137 antisense target binding 
affinity for different edit combinations. Luciferase activity is proportional to target gene 
expression, so target affinity is inversely related to luciferase activity. The numeric combinations 
and All correspond to various edit combinations, Control corresponds to a positive control (binds 
strongly to the target), PL corresponds to a negative control (does not bind to the target), and WT 
corresponds to WT miR137.  
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Figure 4 
 
A molecular model of interactions that contribute to schizophrenia risk. This schematic 
depicts the biochemical model constructed and subsequently simulated using MATLAB. The 
curved lines represent RNA molecules, the brown circles represent A-to-I edits, standard arrows 
represent promotion, and barred arrows represent inhibition.  
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Figure 5 
 
The presence of the rs1625579 risk SNP increases schizophrenia-related inflammatory 
burden. This plot portrays the inflammatory burden output of the IFN-miR137-ADAR1 
mathematical model with and without the rs1625579 risk SNP. The orange line corresponds to 
the results in the presence of the risk SNP and the blue line corresponds to the results in the 
absence of the risk SNP.  
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Figure 6 
Call: 
lm(formula = IBFC ~ rEDIT, data = re) 
 
Residuals: 
       Min         1Q     Median         3Q        Max  
-4.394e-05 -1.919e-05 -5.200e-08  1.923e-05  4.404e-05  
 
Coefficients: 
             Estimate Std. Error t value Pr(>|t|)     
(Intercept) 1.045e+00  1.615e-05   64689   <2e-16 *** 
rEDIT       2.496e-02  1.664e-04     150   <2e-16 *** 
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 2.84e-05 on 12 degrees of freedom 
Multiple R-squared:  0.9995, Adjusted R-squared:  0.9994  
F-statistic: 2.25e+04 on 1 and 12 DF,  p-value: < 2.2e-16 
 
A-to-I editing of miR137 significantly influences the effect of the rs1625579 risk SNP on 
schizophrenia-related inflammatory burden. This figure represents the output of the statistical 
analysis on inflammatory burden fold change under different miR137 editing rate conditions. 
The analysis was performed using a standard linear regression approach, where inflammatory 
burden fold change was modeled using basal editing rate as the predictor (while all other factors 
were held constant). The basal editing rate significantly affected inflammatory burden fold 
change (p < 2 x 10-16).  
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Figure 7 
 
A holistic schizophrenia risk model framework that incorporates genetic risk, 
environmental risk, and gene-environment interaction. This figure represents a holistic 
conceptual risk model framework for schizophrenia posited based on the findings of this study. 
The enclosed terms represent causal or intermediary entities, while the arrows represent causal 
relationships. The term “GxE” is used here as shorthand for gene-environment interaction.  
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APPENDIX 
Supplementary Table 1 
 
Multiple sites on miR137 are edited in vivo at levels significantly higher than background 
changes. This table displays the base-modification read data from the high throughput RNA-
sequencing experiment that met significance criteria under a Poisson distribution. Reference 
Base refers to the WT base and Error Base refers to the base read by the sequencer.  
 
 
 
 
 
 
Position Reference Base Consensus Count Tissue Error Base Error Base Count
29 A 8609 Fetal Human Brain G 4
41 A 8609 Fetal Human Brain G 4
43 A 8609 Fetal Human Brain G 3
44 A 8609 Fetal Human Brain G 4
50 A 8609 Fetal Human Brain G 4
53 A 8609 Fetal Human Brain G 5
61 A 8609 Fetal Human Brain G 4
69 A 8609 Fetal Human Brain G 8
71 A 8609 Fetal Human Brain G 4
72 A 8609 Fetal Human Brain G 12
74 A 8609 Fetal Human Brain G 12
29 A 1469 Adult Mouse Brain G 48
61 A 1469 Adult Mouse Brain G 14
68 A 1469 Adult Mouse Brain G 4
69 A 1469 Adult Mouse Brain G 82
71 A 1469 Adult Mouse Brain G 3
72 A 1469 Adult Mouse Brain G 11
74 A 1469 Adult Mouse Brain G 118
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Supplementary Figure 1 
Response hsaACTB 
 
Effect Tests 
Source Nparm DF Sum of 
Squares 
F Ratio Prob > F  
Plasmid 9 9 37.535475 1.4211 0.2474  
 
Least Squares Means Table 
Level Least Sq 
Mean 
 Std Error Mean 
a119g 28.194555  0.9890734 28.1946 
a119g-a124g 29.129404  0.9890734 29.1294 
a124g 28.179814  1.2113626 28.1798 
a79g 29.026718  0.9890734 29.0267 
a79g-a119g 27.558155  0.9890734 27.5582 
a79g-a119g-a124g 28.604111  0.9890734 28.6041 
a79g-a124g 30.555158  0.9890734 30.5552 
None 26.241238  0.9890734 26.2412 
pCMVmiR137 27.264446  0.9890734 27.2644 
pCMVPL 27.797063  0.9890734 27.7971 
 
Response hsaGAPDH202 
 
Effect Tests 
Source Nparm DF Sum of 
Squares 
F Ratio Prob > F  
Plasmid 9 9 50.368116 1.5206 0.2109  
 
Least Squares Means Table 
Level Least Sq 
Mean 
 Std Error Mean 
a119g 30.210362  1.1076074 30.2104 
a119g-a124g 31.547063  1.1076074 31.5471 
a124g 30.011102  1.3565365 30.0111 
a79g 31.265220  1.1076074 31.2652 
a79g-a119g 29.465520  1.1076074 29.4655 
a79g-a119g-a124g 30.359163  1.1076074 30.3592 
a79g-a124g 32.977412  1.1076074 32.9774 
None 28.171171  1.1076074 28.1712 
pCMVmiR137 29.198672  1.1076074 29.1987 
pCMVPL 29.506629  1.1076074 29.5066 
 
Response Pre-miR137 
 
Effect Tests 
Source Nparm DF Sum of 
Squares 
F Ratio Prob > F  
Plasmid 9 9 172.79586 1.5763 0.1928  
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Least Squares Means Table 
Level Least Sq 
Mean 
 Std Error Mean 
a119g 22.618089  2.0149759 22.6181 
a119g-a124g 25.152132  2.0149759 25.1521 
a124g 22.239349  2.4678314 22.2393 
a79g 22.484688  2.0149759 22.4847 
a79g-a119g 22.994235  2.0149759 22.9942 
a79g-a119g-a124g 22.360327  2.0149759 22.3603 
a79g-a124g 23.163958  2.0149759 23.1640 
None 28.677297  2.0149759 28.6773 
pCMVmiR137 22.822852  2.0149759 22.8229 
pCMVPL 28.764065  2.0149759 28.7641 
 
The luciferase reporter-based target affinity data does not represent differences in 
construct expression. This figure presents the output of a regression of the luciferase data 
against RT-PCR data for each construct. All of the p-values exceed 0.05, which suggests that the 
luciferase data is not explained by variation in expression of the various plasmids used in the 
luciferase experiments.  
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Supplementary Figure 2 
 
The IFN-miR137-ADAR1 mathematical model exhibits biologically plausible input-output 
dynamics across time. This graph displays the results of a simulation of the IFN-miR137-
ADAR1 mathematical model for a periodic infection input. Pathogen levels (corresponding to 
the periodic infection input) are in blue.  
 
Supplementary Computational Methods 
The square-wave pathogen input function was constructed in MATLAB as follows: 
function [out] = SquareWave (t, period, length, high, low) 
if (mod(t,period) <= length) 
    out = high; 
else 
    out = low; 
end 
 
The ODE system employed in this study was implemented in MATLAB as follows:  
function [dydt] = IFNmir137Model(t,y,parameters) 
% Order of Quantities: Pathogen, IFN, ADAR1-A Level, Total miR137, TCF4 
% mRNA, TCF4 protein, Dendritic Cells, Inflammation Burden. 
% Order of parameters: Pathogen period, pathogen length, pathogen high,  
% pathogen low, pathogen clearance rate, IFN release rate per DC per pathogen 
unit,  
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% IFN degradation rate, ADAR1-A synthesis rate per IFN, ADAR1-A degradation 
rate,  
% basal miR137 transcription rate, binary rs1625579 
% presence, miR137 degradation rate, basal 
% editing rate, ADAR1-B level, TCF4 transcription rate, 
% TCF4 degradation rate, miR137-TCF4 targeting Vmax, miR137-TCF4 targeting 
% Km, TCF4 protein production Vmax, TCF4 protein production Km, TCF4 
% protein degradation Vmax, TCF4 protein degradation Km, DC basal production 
rate, DC replication rate per TCF4 protein,  
% DC degradation rate, Inflammation factor.  
dydt = zeros(8,1); 
dydt(1) = 
SquareWave(t,parameters(1),parameters(2),parameters(3),parameters(4)) - 
parameters(5)*y(1); 
dydt(2) = parameters(6)*y(1)*y(7) - parameters(7)*y(2); 
dydt(3) = parameters(8)*y(2) - parameters(9)*y(3); 
dydt(4) = parameters(10)*(1 - 0.3*parameters(11))*(1 + 2.98*(y(3)/20)) - 
parameters(12)*y(4); 
E = parameters(13)*(1 + (0.6*y(4))/parameters(14)); 
dydt(5) = parameters(15) - parameters(16)*y(5) - 
.16*(E*y(4)*y(5)*parameters(17))/(parameters(18)+y(5)) - ((1-
E)*y(4)*y(5)*parameters(17))/(parameters(18)+y(5)); 
dydt(6) = (parameters(19)*y(5))/(parameters(20) + y(5)) - 
(parameters(21)*y(6))/(parameters(22)+y(6)); 
dydt(7) = parameters(23) + parameters(24)*y(6) - parameters(25)*y(7); 
dydt(8) = parameters(26)*y(2); 
end 
 
The sensitivity analysis method was implemented in MATLAB as follows: 
function [out] = SNPcompare 
(t,y,tspan,y0,want,test,parameters,varySet,lower,upper,steps) 
% Initialize inputs and outputs 
set = varySet; 
curr = parameters(set); 
currL = curr*(1-(lower/100)); 
currU = curr*(1+(upper/100)); 
for idx = 1:length(curr) 
    vec = linspace(currL(idx),currU(idx),steps); 
    if idx == 1 
        mat = vec; 
    else 
        mat = combvec(mat,vec); 
    end 
end 
mat = mat'; 
out = [mat, zeros(size(mat,1),1)]; 
progressbar; 
  
% Scan through parameter values and compute the output metrics 
for idx = 1:size(mat,1) 
    parms = parameters; 
    parms(set) = mat(idx,:)'; 
    parms(test) = 0; 
    [~,yn] = ode45(@(t,y) IFNmir137Model(t,y,parms),tspan,y0); 
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    yS0 = yn(end,want); 
    parms(test) = 1; 
    [~,yn] = ode45(@(t,y) IFNmir137Model(t,y,parms),tspan,y0); 
    yS1 = yn(end,want); 
    out(idx,end) = yS1/yS0; 
    progressbar(idx/size(mat,1)); 
end 
end 
 
 
 
